Sign In
Buy ASND
$243.91
-7.16 (-2.85%)
At Close: Jul 31, 2026
The
Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript | AlphaStreet
04:51pm, Wednesday, 30'th Sep 2020
Ascendis Pharma A/S (NASDAQ: ASND) Q2 2020 earnings call dated Aug. 27, 2020
Neuberger Berman Group LLC Grows Position in AMBEV S A/S (NYSE:ABEV)
07:48am, Monday, 28'th Sep 2020
Neuberger Berman Group LLC boosted its stake in shares of AMBEV S A/S (NYSE:ABEV) by 46.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 380,238 shares of the company’s stock
Genmab A/S (NASDAQ:GMAB) Shares Gap Down to $38.20
08:36am, Friday, 25'th Sep 2020
Genmab A/S (NASDAQ:GMAB) gapped down before the market opened on Wednesday . The stock had previously closed at $38.20, but opened at $33.26. Genmab A/S shares last traded at $34.81, with a volume of
The Global Crushing Equipment Market will grow by $ 281.30 mn during 2020-2024
Genmab A/S (NASDAQ:GMAB) Hits New 1-Year High at $38.79
01:58am, Sunday, 20'th Sep 2020
Shares of Genmab A/S (NASDAQ:GMAB) hit a new 52-week high on Friday . The stock traded as high as $38.79 and last traded at $38.73, with a volume of 4085 shares changing hands. The stock had previousl
Andersen & Martini A/S : Offer to buy back shares | MarketScreener
04:56pm, Tuesday, 15'th Sep 2020Ascendis Pharma A/S (ASND) Q2 2020 Earnings Call Transcript | The Motley Fool
02:00am, Friday, 28'th Aug 2020
ASND earnings call for the period ending June 30, 2020.
Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2020 Results - Earnings Call Transcript
11:48pm, Thursday, 27'th Aug 2020
Ascendis Pharma A/S (NASDAQ:ASND) Q2 2020 Earnings Conference Call August 27, 2020, 16:30 ET Company Participants Scott Smith - CFO & SVP Jan Mikkelsen - President & CEO Dana Pizzuti - SVP, De
The Global Industrial Girth Gear Market will grow by $ 23.97 mn during 2020-2024
Ascendis Pharma A/S Announces Second Quarter 2020 Financial Results and Business Update Conference Call on August 27
08:01pm, Thursday, 13'th Aug 2020
COPENHAGEN, Denmark, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical ne
Ascendis' Dwarfism Candidate Gets Orphan Drug Status in EU
04:48pm, Thursday, 13'th Aug 2020
Ascendis' (ASND) TransCon CNP receives an Orphan Drug tag in Europe for the treatment of achondroplasia, the most common type of dwarfism.
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ CNP for the Treatment of Achondroplasia in Europe
11:05am, Wednesday, 12'th Aug 2020
COPENHAGEN, Denmark, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs
Rockwell Automation Holding Up On Recovery And Reshoring Expectations (NYSE:ROK)
06:29pm, Tuesday, 04'th Aug 2020
Rockwell posted a modest segment-level beat in the fiscal third quarter, with better results in the A&S segment.
Ascendis Pharma A/S Announces Upcoming Investor Presentations in August
12:30pm, Tuesday, 04'th Aug 2020
COPENHAGEN, Denmark, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical ne
